This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Mar;56(3):723-5.

doi: 10.1016/j.jhep.2011.08.023. Epub 2011 Nov 27.

Sorafenib use while waiting for liver transplant: we still need to wait

Richard S Finn¹

Affiliations

Affiliation

¹ Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California-Los Angeles, 10833 Le Conte Ave., 11-934 Factor Bldg., Los Angeles, CA 90095, USA. Rfinn@mednet.ucla.edu

PMID: 22127280
DOI: 10.1016/j.jhep.2011.08.023

Free article

Comment

Sorafenib use while waiting for liver transplant: we still need to wait

Richard S Finn. J Hepatol. 2012 Mar.

Free article

. 2012 Mar;56(3):723-5.

doi: 10.1016/j.jhep.2011.08.023. Epub 2011 Nov 27.

Author

Richard S Finn¹

Affiliation

¹ Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California-Los Angeles, 10833 Le Conte Ave., 11-934 Factor Bldg., Los Angeles, CA 90095, USA. Rfinn@mednet.ucla.edu

PMID: 22127280
DOI: 10.1016/j.jhep.2011.08.023

No abstract available

PubMed Disclaimer

Comment on

Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety.
Vitale A, Volk ML, Pastorelli D, Lonardi S, Farinati F, Burra P, Angeli P, Cillo U. Vitale A, et al. Hepatology. 2010 Jan;51(1):165-73. doi: 10.1002/hep.23260. Hepatology. 2010. PMID: 19877181

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science